1. Customer Pain and Solution.
a. Problem
WHO pinpoints the hesitancy to vaccinate as the top 10 threat to global health. Fear of needles (“trypanophobia”) is the major obstacle to increasing adherence to vaccination that impacts 10% to 25% of the global population. Trypanophobia results in poor compliance or even full abandonment of treatment. Another problem is poor economics of subcutaneous injection technology that hinders adoption of many beneficial dermatological and cosmeutic procedures.
b. Solution
Skinport microneedle arrays are minimally invasive devices that painlessly bypass skin and provide efficient intradermal penetration which:
- increases adherence to the therapy
- decreases API/antigen load
- allows self-administration to decrease waiting time and nursing cost
- facilitates continuous collection of biomaterials for patient monitoring
Importantly, our product is based on hollow silicon microneedles that carry many advantages over the widespread biodegra...
1. Customer Pain and Solution.
a. Problem
WHO pinpoints the hesitancy to vaccinate as the top 10 threat to global health. Fear of needles (“trypanophobia”) is the major obstacle to increasing adherence to vaccination that impacts 10% to 25% of the global population. Trypanophobia results in poor compliance or even full abandonment of treatment. Another problem is poor economics of subcutaneous injection technology that hinders adoption of many beneficial dermatological and cosmeutic procedures.
b. Solution
Skinport microneedle arrays are minimally invasive devices that painlessly bypass skin and provide efficient intradermal penetration which:
- increases adherence to the therapy
- decreases API/antigen load
- allows self-administration to decrease waiting time and nursing cost
- facilitates continuous collection of biomaterials for patient monitoring
Importantly, our product is based on hollow silicon microneedles that carry many advantages over the widespread biodegradable microneedles.

2. Overall Impact
a. The 1 year and 5-year impact that we hope to accomplish
1 year: to carry out the registration of a medical device, clinical trials and release a pilot batch of 5 thousand applicators for vaccines. Year 5: produce 10-15 million applicators for vaccines and 2-5 million for cosmetology annually, develop, test and certify models for injecting multicomponent drugs and a model for monitoring medicines in the patient's body. To make an experimental batch of 1000 each. Enter the European and Asian markets.
3. Customer Needs and Acquisition
a. Potential market and addressable market size
WHO reports 2,5 bln. vaccine injections per year, and it will grow dramatically with COVID-19. Coherent Market insight: Just Microneedle Flu Vaccine Market To Surpass US$ 2006.5 Million By 2027. Thus SkinPort ® allocated in the segment with hight CAGR.
b. Market validation
Two Russian vaccine manufacturers confirmed their interest in clinical trials of Skinport device. Two manufacturers of cosmetic injections are ready to purchase experimental batches as soon as the industrial production is established.
c. Marketing - messaging to users & customers and plan to spread that message
Our innovative, pain-free applicator will increase the compliance and efficiency of delivery of life vital medicines to everybody and for child specifically. Social networks and direct advertising inform about the advantages of the new delivery tool.
More information
+1

Advisors

Serge Scotto
Admin
Serge Scotto Healthcare Executive, Founding Partner, Board Member, Pharmaceutical, Wellbeing, M&A, Business Development

Employees

Константин Певчих
Admin
Константин Певчих CEO Experienced Manager, technology entrepreneur, and math engineer. Leader and co-founder of several material based startups, including AI.

Recommendations

I know Konstantin Pevjchikh and his project IGLA for more then a year. I may assure you that both the IGLA team and the project itself are of the highest quality. They possess all: the tangible technology, professionalism, and energy. They solve real problem with true technological innovation. Highly recommended!